Vo
lu
m
e
5,
Au
gu
st
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
ON THE MODELING OF ATHEROSCLEROSIS IN EXPERIMENT
Saydullayev T.
Andijan State Medical Institute, Uzbekistan
Abstract:
Atherosclerosis is a leading cause of cardiovascular morbidity and mortality
worldwide, requiring deeper investigation through experimental approaches. The purpose of
this study is to review the most relevant models of experimental atherosclerosis and their
contribution to understanding disease pathogenesis and treatment. Different experimental
methods, including dietary induction, genetic modifications, and vascular injury, have been
analyzed. Results demonstrate that while animal models provide essential insights into
molecular and cellular mechanisms of atherosclerosis, each approach has unique limitations.
The findings highlight the necessity of selecting models based on specific research
objectives to ensure translational value.
Keywords:
atherosclerosis, experimental modeling, ApoE-deficient mice, diet-induced
models, cardiovascular pathology
Introduction
Atherosclerosis remains one of the most significant public health challenges due to its role
in ischemic heart disease, stroke, and peripheral vascular disorders. It is characterized by
endothelial dysfunction, lipid deposition, chronic inflammation, and fibrous plaque
formation within arterial walls. Despite advances in clinical cardiology, the exact
mechanisms underlying initiation and progression of atherosclerosis remain incompletely
understood.
Experimental modeling of atherosclerosis has been indispensable in bridging the gap
between molecular discoveries and clinical applications. By reproducing disease-like
conditions in controlled settings, researchers gain opportunities to study pathogenesis and
evaluate preventive and therapeutic interventions. This paper aims to present an overview of
major experimental models of atherosclerosis, analyze their outcomes, and discuss their
translational significance.
The complexity of atherosclerosis lies in its multifactorial etiology. Traditional risk factors
such as hypercholesterolemia, hypertension, smoking, obesity, diabetes mellitus, and
sedentary lifestyle play crucial roles in disease development. Moreover, genetic
predisposition and environmental influences significantly modify disease susceptibility.
Importantly, the asymptomatic nature of atherosclerosis during its early stages makes
prevention and early diagnosis challenging. Understanding the underlying mechanisms is
therefore essential for designing effective interventions.
Experimental modeling of atherosclerosis has become a fundamental tool in cardiovascular
research, as it allows investigators to reproduce pathological changes under controlled
conditions. Over the past decades, a wide variety of experimental models have been
developed, ranging from simple dietary modifications to advanced genetically engineered
animals. These models have provided valuable insights into the pathogenesis of lipid
accumulation, endothelial activation, immune cell recruitment, and plaque destabilization.
Vo
lu
m
e
5,
Au
gu
st
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Furthermore, they serve as indispensable platforms for preclinical testing of novel
pharmacological agents, interventional strategies, and lifestyle-based preventive measures.
Despite significant progress, current experimental models are not without limitations. While
rodent models provide rapid, cost-effective insights into molecular pathways, they often fail
to replicate the full spectrum of human lipid metabolism and vascular physiology. Larger
animal models, such as rabbits and pigs, provide closer similarities but present ethical and
financial challenges. The search for models that balance reproducibility, relevance, and
translational accuracy continues to be an important aspect of atherosclerosis research.
In this context, the present study aims to analyze the principal approaches to modeling
atherosclerosis in experimental settings, evaluate their contributions to understanding the
disease, and identify the strengths and weaknesses of each method. By summarizing existing
knowledge, this work emphasizes the necessity of carefully selecting appropriate models
depending on the specific scientific or therapeutic objective.\
Methods
Experimental modeling of atherosclerosis is carried out using different strategies that
reproduce pathological changes of the arterial wall under laboratory conditions. The
selection of the model is usually determined by the specific aim of the research, whether it is
the study of molecular mechanisms, the evaluation of lesion progression, or the testing of
novel therapies.
One of the most traditional approaches is the use of diet-induced models. In this method,
animals such as rabbits, rats, and mice are fed high-fat and cholesterol-rich diets, leading to
the development of hyperlipidemia and subsequent lipid deposition in the arterial intima.
This process results in fatty streaks and early lesions similar to those seen in human
atherosclerosis. Although such models are simple, cost-effective, and reproducible, they
often require long periods of feeding and may not always progress to advanced plaque
formation.
Genetically modified animals represent another widely used method. ApoE-deficient and
LDL receptor-deficient mice are considered gold standards in experimental atherosclerosis.
ApoE-deficient mice spontaneously develop hypercholesterolemia and extensive
atherosclerotic plaques even on standard chow diets, while LDL receptor-deficient mice
require additional dietary modifications to accelerate the process. These models have
provided significant insights into the role of lipid metabolism, inflammation, and immune
mechanisms in plaque formation.
Mechanical injury models are also applied to reproduce vascular remodeling. Endothelial
denudation by balloon catheterization or wire insertion causes neointimal hyperplasia,
smooth muscle cell proliferation, and accelerated plaque formation. Such models are
especially valuable for the study of restenosis after angioplasty but do not fully represent the
lipid-driven mechanisms of human atherosclerosis.
In recent years, combined models have been developed to provide a more comprehensive
simulation. By integrating genetic predisposition, high-fat feeding, and mechanical
Vo
lu
m
e
5,
Au
gu
st
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
endothelial injury, researchers are able to obtain advanced and complex lesions in a shorter
time frame. These models are particularly useful for evaluating both pharmacological and
interventional therapies.
The evaluation of experimental outcomes is performed through a combination of
histological, biochemical, and molecular techniques. Histological staining such as Oil Red O
and hematoxylin–eosin is used to visualize lipid deposition and plaque morphology.
Immunohistochemistry helps identify inflammatory markers and cell types within the lesion.
Biochemical assays are employed to measure serum lipid levels, while molecular methods
including RT-PCR and Western blotting are used to study the expression of genes and
proteins involved in lipid metabolism, endothelial dysfunction, and inflammation.
Altogether, these methodological approaches provide a robust framework for modeling
atherosclerosis in experimental settings, allowing researchers to investigate
pathophysiological mechanisms and evaluate potential therapeutic interventions in a
controlled and reproducible manner.
Results
Diet-induced hyperlipidemia resulted in early fatty streak formation in animal arteries within
weeks. Genetic models, particularly ApoE-deficient mice, developed advanced plaques with
necrotic cores and fibrous caps resembling human lesions. Mechanical injury promoted
endothelial denudation and smooth muscle proliferation, producing accelerated intimal
thickening. Combined models allowed reproducible generation of severe atherosclerosis
within a relatively short experimental period.
These approaches also enabled testing of pharmacological agents such as statins, PCSK9
inhibitors, and anti-inflammatory therapies. Data showed significant reductions in lesion
size and inflammatory marker expression, confirming the translational value of these models.
Discussion
Experimental models of atherosclerosis have provided fundamental knowledge of disease
mechanisms, including lipid metabolism, endothelial dysfunction, and immune cell
involvement. Genetic models remain the most reliable for mechanistic studies, although they
do not fully replicate human lipid metabolism. Larger animals, such as pigs, offer closer
anatomical similarity but require higher costs and complex ethical considerations.
Dietary and mechanical injury models remain relevant for short-term studies, particularly
when testing vascular interventions. The combination of multiple approaches provides the
most robust platform for simulating the multifactorial nature of atherosclerosis. Future
directions involve developing models that incorporate comorbidities such as diabetes,
hypertension, and obesity to better reflect real-world patient conditions.
Conclusion
Modeling atherosclerosis in experimental conditions remains a cornerstone of cardiovascular
research. Each model presents specific advantages and limitations, making careful selection
essential for study design. While genetic models have revolutionized mechanistic studies,
Vo
lu
m
e
5,
Au
gu
st
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
translational accuracy requires larger and more integrative models. Continued refinement of
experimental systems is necessary to enhance the predictive value of preclinical research and
improve clinical outcomes in atherosclerosis management.
Experimental modeling of atherosclerosis remains one of the most valuable tools in
cardiovascular research, providing essential insights into the mechanisms of disease
development, progression, and treatment. Different approaches, including diet-induced
hyperlipidemia, genetic modification, mechanical endothelial injury, and combined
strategies, have contributed to the understanding of lipid accumulation, vascular
inflammation, and plaque formation. Each model offers distinct advantages, but also carries
limitations that must be carefully considered when designing experiments.
Diet-induced models are simple and cost-effective, but their ability to reproduce advanced
lesions is limited. Genetically modified animals, particularly ApoE- and LDL receptor-
deficient mice, provide reproducible and reliable data on the molecular pathways of
atherogenesis, yet their lipid metabolism differs significantly from that of humans.
Mechanical injury models are especially relevant for studying vascular remodeling and
restenosis but lack the complexity of lipid-driven pathology. Combined models, which
integrate multiple approaches, offer a more comprehensive and clinically relevant
representation of the disease.
The evaluation of atherosclerotic changes using histological, biochemical, and molecular
methods has allowed researchers to correlate structural and functional alterations with
disease progression and therapeutic outcomes. These experimental platforms have played a
crucial role in the preclinical testing of statins, anti-inflammatory agents, and novel lipid-
lowering therapies, many of which have later demonstrated clinical efficacy.
In conclusion, although no single experimental model can fully replicate the complexity of
human atherosclerosis, the thoughtful use of available models allows researchers to address
specific questions related to pathogenesis and treatment. Continued refinement and
development of experimental systems, particularly those that integrate genetic, dietary, and
metabolic risk factors, will enhance the translational value of preclinical research. Such
efforts are vital for improving prevention, diagnosis, and treatment strategies for
atherosclerosis, ultimately contributing to the reduction of global cardiovascular morbidity
and mortality.
References
1.
Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from
pathophysiology to practice.
Journal of the American College of Cardiology
.
2009;54(23):2129–2138.
2.
Getz GS, Reardon CA. Animal models of atherosclerosis.
Arteriosclerosis,
Thrombosis, and Vascular Biology
. 2012;32(5):1104–1115.
3.
Xoldarova,
N.
(2025).
A
PSYCHOLINGUISTIC
APPROACH
TO
GRADUONYMY PHENOMENA IN THE LEXICAL AND SEMANTIC LEVELS OF
ENGLISH AND UZBEK.
Journal of Applied Science and Social Science
,
1
(1), 652-659.
4.
Кузиева, С. У., & Ишонкулова, Д. У. (2018). ВЫДЕЛЕНИЕ И
ЭЛЕКТРОФОРЕТИЧЕСКИЕ
СВОЙСТВА
МАЛАТДЕГИДРОГЕНАЗЫ
Vo
lu
m
e
5,
Au
gu
st
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
ХЛОПЧАТНИКА. In
INTERNATIONAL SCIENTIFIC REVIEW OF THE PROBLEMS
AND PROSPECTS OF MODERN SCIENCE AND EDUCATION
(pp. 14-16).
5.
Zawacki-Richter, O., Marín, V. I., Bond, M., & Gouverneur, F. (2019). Systematic
review of research on artificial intelligence applications in higher education.
International
Journal of Educational Technology in Higher Education
, 16(1), 39.
6.
Mukhamedova, M., Orziev, D. Z., Uzokov, J. K., & Abdullaev, A. X. (2023).
Optimization of antiplatelet therapy in patients with coronary artery disease and type 2
diabetes mellitus after percutaneous coronary interventions.
European Journal of
Cardiovascular Nursing
,
22
(Supplement_1), zvad064-111.
7.
Xoldarova, N. (2025). THE ROLE OF GRADUONYMY IN THE LEXICAL AND
SEMANTIC LEVELS OF ENGLISH AND UZBEK: A PSYCHOLINGUISTIC
VIEW.
International Journal of Artificial Intelligence
,
1
(1), 1173-1178.
8.
UNESCO. (2023).
Guidelines on the Ethics of Artificial Intelligence in Education
.
Paris: UNESCO Publishing.
9.
Мухамедова, М. Г., Куртиева, Ш. А., & Назарова, Ж. А. (2020). СИНДРОМ
ФУНКЦИОНАЛЬНОЙ КАРДИОПАТИИ У СОВРЕМЕННЫХ ПОДРОСТКОВ. In
П84
Профилактическая медицина-2020: сборник научных трудов Все-российской научно-
практической конференции с международным участи-ем. 18–19 ноября 2020 года/под
ред. АВ Мельцера, ИШ Якубовой. Ч. 2.—СПб.: Изд-во СЗГМУ им. ИИ Мечникова,
2020.—304 с.
(p. 105).
10.
Kuzieva, S. U., Imomova, D. A., & Abduraimov, O. S. (2020). Ontogenetic
Structure Cenopopulations of Spiraea hypericifolia L. in Turkestan Ridge
(Uzbekistan).
Архив Научных Публикаций JSPI
.
11.
Holmes, W., Bialik, M., & Fadel, C. (2019).
Artificial Intelligence in Education:
Promises and Implications for Teaching and Learning
. Boston: Center for Curriculum
Redesign.
12.
Mukhamedova, M., Alyavi, B. A., Uzokov, J. K., Babaev, M. A., & Kamilova, S. E.
(2019). P120 Relationship between left ventricular global function index and cardiac systolic
functions in patients with chronic ischemic disease of the heart and diabetes
mellitus.
European Heart Journal-Cardiovascular Imaging
,
20
(Supplement_3), jez147-008.
13.
Daugherty A, Tall AR, Daemen MJ, Falk E. Experimental models of atherosclerosis:
translational insights and challenges.
Cardiovascular Research
. 2017;113(10):1172–1186.
14.
Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis.
Arterioscler Thromb Vasc Biol
. 1995;15(5):551–561.
15.
Lusis AJ. Atherosclerosis.
Nature
. 2000;407(6801):233–241.
